Guidelines for clinical trials of new therapeutic agents in multiple sclerosis: Relations between study investigators, advisors, and sponsors

Fred D. Lublin; Stephen C. Reingold

doi:10.1212/WNL.48.3.572

Guidelines for clinical trials of new therapeutic agents in multiple sclerosis: Relations between study investigators, advisors, and sponsors

Fred D. Lublin
, Stephen C. Reingold

Research output: Contribution to journal › Review article › peer-review

26 Scopus citations

Original language	English
Pages (from-to)	572-574
Number of pages	3
Journal	Neurology
Volume	48
Issue number	3
DOIs	https://doi.org/10.1212/WNL.48.3.572
State	Published - Mar 1997
Externally published	Yes

Access to Document

10.1212/WNL.48.3.572

Cite this

@article{641cc2c80b7a422d81a01b8125f2c529,

title = "Guidelines for clinical trials of new therapeutic agents in multiple sclerosis: Relations between study investigators, advisors, and sponsors",

author = "Lublin, \{Fred D.\} and Reingold, \{Stephen C.\}",

year = "1997",

month = mar,

doi = "10.1212/WNL.48.3.572",

language = "English",

volume = "48",

pages = "572--574",

journal = "Neurology",

issn = "0028-3878",

publisher = "Lippincott Williams and Wilkins",

number = "3",

}

TY - JOUR

T1 - Guidelines for clinical trials of new therapeutic agents in multiple sclerosis

T2 - Relations between study investigators, advisors, and sponsors

AU - Lublin, Fred D.

AU - Reingold, Stephen C.

PY - 1997/3

Y1 - 1997/3

UR - https://www.scopus.com/pages/publications/0030979128

U2 - 10.1212/WNL.48.3.572

DO - 10.1212/WNL.48.3.572

M3 - Review article

C2 - 9065528

AN - SCOPUS:0030979128

SN - 0028-3878

VL - 48

SP - 572

EP - 574

JO - Neurology

JF - Neurology

IS - 3

ER -